Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa

Eur J Clin Nutr. 2009 Jul;63(7):850-7. doi: 10.1038/ejcn.2008.78. Epub 2009 Jan 28.

Abstract

Background/objective: The efficacy of zinc combined with vitamin A or multiple micronutrients in preventing diarrhoea is unclear in African countries with high prevalence of human immunodeficiency virus (HIV)-exposed children. Potential modifying factors, such as stunting, need to be addressed. The objective of this study was to determine whether adding zinc or zinc plus multiple micronutrients to vitamin A reduces diarrhoea incidence, and whether this differs between the strata of stunted or HIV-infected children.

Methods: We analyzed data from a randomized, controlled, double-blinded trial (ClinicalTrials.gov NCT00156832) of prophylactic micronutrient supplementation to children aged 6-24 months. Three cohorts of children: 32 HIV-infected children, 154 HIV-uninfected children born to HIV-infected mothers and 187 uninfected children born to HIV-uninfected mothers, received vitamin A, vitamin A plus zinc or multiple micronutrients, which included vitamin A and zinc. The main outcome was incidence of diarrhoea. Poisson regression was used in intent-to-treat analyses. Stratified analyses followed testing for statistical interaction between intervention and stunting.

Results: We observed no significant differences in overall diarrhoea incidence among treatment arms. Stunting modified this effect with stunted HIV-uninfected children having significantly lower diarrhoea incidence when supplemented with zinc or multiple micronutrients compared with vitamin A alone (2.04 and 2.23 vs 3.92 episodes/year, respectively, P=0.024). No meaningful subgroup analyses could be done in the cohort of HIV-infected children.

Conclusions: Compared with vitamin A alone, supplementation with zinc and with zinc and multiple micronutrients, reduced diarrhoea morbidity in stunted rural South African children. Efficacy of zinc supplementation in HIV-infected children needs confirmation in studies that represent the spectrum of disease severity and age groups.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Diarrhea, Infantile / epidemiology*
  • Diarrhea, Infantile / prevention & control
  • Dietary Supplements
  • Double-Blind Method
  • Ferrous Compounds / administration & dosage
  • Ferrous Compounds / therapeutic use
  • Gluconates / therapeutic use
  • Growth Disorders / complications*
  • HIV Infections / complications
  • Humans
  • Incidence
  • Infant
  • Iron / administration & dosage
  • Iron / adverse effects
  • Iron / therapeutic use
  • Micronutrients / adverse effects
  • Micronutrients / therapeutic use*
  • Nutrition Disorders / prevention & control
  • Rural Population
  • South Africa
  • Vitamin A / administration & dosage
  • Vitamin A / therapeutic use*
  • Zinc / administration & dosage
  • Zinc / adverse effects
  • Zinc / therapeutic use*

Substances

  • Ferrous Compounds
  • Gluconates
  • Micronutrients
  • Vitamin A
  • Iron
  • Zinc
  • gluconic acid
  • ferrous fumarate

Associated data

  • ClinicalTrials.gov/NCT00156832